<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CD10, a proteolytic enzyme seen in germinal center cells and in the majority of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, is occasionally expressed in diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>To clarify the origin and cellular characteristics of CD10-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, we analyzed 36 de novo cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> for <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> of the immunoglobulin heavy chain variable region (VH) genes and for their immunophenotypes </plain></SENT>
<SENT sid="2" pm="."><plain>Expression greater than that of grade 2 Bcl-6 was observed in 11 of the 30 CD10-negative cases (37%) and in <z:hpo ids='HP_0000001'>all</z:hpo> six CD10-positive cases (100%; P &lt; 0.05) without expression of CD5, CD23, cyclin D1, CD30 or CD138 </plain></SENT>
<SENT sid="3" pm="."><plain>The average mutation frequencies of the six CD10-positive and 30 CD10-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> were 12.9 and 9.8%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The range of SM frequencies in CD10-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (9.52-18.06) was distinctly narrower than that observed for CD10-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (0.69-26.89) </plain></SENT>
<SENT sid="5" pm="."><plain>These findings seem to indicate that CD10-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, originating from germinal center B cells, is a genetically and immunophenotypically more homogeneous group than CD10-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, three extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, in five of the six CD10-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, showed ongoing mutation, indicating that antigen-driven, high-affinity <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> may play an important role in clonal expansion in CD10-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> four extranodal cases of the six CD10-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> showed ongoing mutation and/or bcl-2/JH rearrangement </plain></SENT>
<SENT sid="8" pm="."><plain>This result suggests that the cell origin of extranodal CD10-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> may be the same as that of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>